Back to Trades
Total Value
$1.3M
Filing Date
Mar 10, 2026
1 transactions
Trade Summary
On Mar 7, 2026, Lalwani Nikhil, PRESIDENT & CEO, Director, reported $1.3M of ANI PHARMACEUTICALS INC (ANIP) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $74.04. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Name
- Lalwani Nikhil
- Role
- PRESIDENT & CEO, Director
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Mar 10, 2026
- Transaction Date
- Mar 7, 2026
- Accession Number
- 0001822629-26-000008
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 7, 2026 | Common Stock | 17,060 | $74.04 | Tax Withholding | $1.3M |
Want live alerts when Lalwani Nikhil trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.